Olink: Understanding human disease in the post-genomics era
OLink is a high quality proteomics company, involved in the UK Biobank Pharma Proteomics Project, that resulted in an updated genetic atlas of the plasma proteome. With the recent establishment of the Oxford-GSK Institute, Olink® Explore will be utilized to build a multiomics approach to mapping molecular mechanisms of complex diseases such as Parkinson’s and Alzheimer’s. Expertise in machine learning and bioinformaticians at Oxford’s Big Data Institute will be able to leverage these datasets to pinpoint novel targets and identify signatures to stratify patients.
Date: 2 February 2023, 12:00 (Thursday, 3rd week, Hilary 2023)
Venue: IMS-Tetsuya Nakamura Building, Roosevelt Dr, Headington OX3 7TY
Venue Details: Institute of Developmental and Regenerative Medicine (IDRM) IMS-Tetsuya Nakamura Building, Old Road Campus, Roosevelt Dr, Headington, Oxford OX3 7TY and Zoom
Speakers: Mariana Fontes (Olink), Daniel Tomé (OLink)
Organising department: Medical Sciences Office
Organisers: Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Betina Nair (University of Oxford)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
Editor: Sheena Lee